by admin | Dec 3, 2025 | News
At the 9th Antifibrotic Drug Development Summit, Dr. Yanling Zhang presented MatrileX’s research poster, “Back to the Future: Using Clinical Trial Design to Enhance the Utility of Preclinical Testing in Fibrotic Diseases.” The poster highlights strategies to...
by admin | Dec 3, 2025 | News
Boston, MA — November 17–19, 2025 — MatrileX Laboratories participated in the 9th Antifibrotic Drug Development Summit, a leading industry forum bringing together experts across fibrosis biology, translational research, and early clinical development. Co-Chair of...
by admin | Dec 2, 2025 | News
MatrileX Laboratories is pleased to announce the publication of our new peer-reviewed study, “Dose-dependent effects of the ACE inhibitor, ramipril, on kidney function and structure in the Alport COL4A3−/− mouse.” The study defines, for the first time, the functional...
by admin | Dec 2, 2025 | News
MatrileX Laboratories is pleased to highlight the publication of a new peer-reviewed study, “Induction of proximal tubular proliferation and lengthening in response to sodium–glucose cotransporter-2 inhibition in experimental rats.” This work provides mechanistic...
